SEC Company Response from MEDICINOVA INC (MNOV) (CIK 0001226616) (MNOV) — Sep 27, 2017
MEDICINOVA INC (MNOV) (CIK 0001226616)
Date: Sept. 27, 2017 · CIK: 0001226616 · Accession: 0001193125-17-296212
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-220593
Letter
September 27, 2017
VIA EDGAR
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 4546
Washington, D.C. 20549
Attention: Ms. Ada D. Sarmento, Senior Counsel
Re: Acceleration Request of MediciNova, Inc.
Registration Statement on Form S-3, filed September 22, 2017
(File No. 333-220593)
Ladies and Gentlemen:
Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, MediciNova, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effectiveness of the above-referenced Registration Statement, to 4:00 p.m., Eastern Time, on Monday, October 2, 2017, or as soon thereafter as practicable.
Thank you for your assistance. If you should have any questions, please contact Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8060.
Very truly yours,
/s/ Yuichi Iwaki
Show Raw Text
CORRESP 1 filename1.htm CORRESP September 27, 2017 VIA EDGAR Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, N.E. Mail Stop 4546 Washington, D.C. 20549 Attention: Ms. Ada D. Sarmento, Senior Counsel Re: Acceleration Request of MediciNova, Inc. Registration Statement on Form S-3, filed September 22, 2017 (File No. 333-220593) Ladies and Gentlemen: Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, MediciNova, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effectiveness of the above-referenced Registration Statement, to 4:00 p.m., Eastern Time, on Monday, October 2, 2017, or as soon thereafter as practicable. Thank you for your assistance. If you should have any questions, please contact Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8060. Very truly yours, /s/ Yuichi Iwaki Yuichi Iwaki President and Chief Executive Officer